Saudi Arabia issues important clarification on Corona vaccines by


© Reuters – The Ministry of Health announced that the two vaccines against the emerging corona virus, Covid-19, approved by the Food and Drug Administration, are the “Pfizer-Biontech” vaccine and the “AstraZeneca-Oxford” vaccine.

They do not reduce or weaken immunity, and they are both safe and protect against severe complications and death from Covid-19.

The Saudi Health Ministry said that there are no recommendations to submit to isolation after receiving the new Corona vaccine.

The Saudi Health Ministry said that there are no recommendations for conducting a laboratory examination before receiving the new Corona vaccine, stressing the importance of continuing to apply general precautionary measures.

The Saudi Ministry of Health added that people recovering from the infection may delay vaccination with the vaccine for 6 months after infection, and receive only one dose.

That is, as the National Committee for Infectious Diseases decided that one dose of the Coronavirus vaccine would be sufficient for those who had previously been infected with the virus, and it would take place after 6 months of recovery.

Data from clinical trials indicate that the two vaccines are safe and effective in people who have had a previous infection with the “Covid-19” virus, and that re-infection within 90 days after the initial infection is very rare.

Yesterday, Saturday, the Ministry of Health announced that the total number of new cases of “Corona” virus (Covid-19) in the Kingdom increased to 377061 confirmed cases, an increase of 338 cases compared to the previous day.

And 320 new recoveries were recorded, bringing the total cases of recovery to 368011 cases, (98% of the total recorded injuries), and the Ministry announced the registration of 5 new deaths, bringing the total number of deaths to 6,488 deaths.

During that day, Sunday’s trading, it fell to the Saudi market by 0.54%, losing about 55 points, down to 9144 points.

Disclosure of risks: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn’t bear any responsibility for any trading losses you might incur as a result of using this data.Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.


Please enter your comment!
Please enter your name here